Related Experiment Video
Updated: Jun 21, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
A mechanism for the suppression of interleukin-1-induced nuclear factor kappaB activation by protein phosphatase
Takeaki Henmi1, Kazutaka Amano, Yuko Nagaura
1Department of Biochemistry, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Insights
Protein phosphatase PP2Ceta-2 inhibits inflammation by blocking the interleukin-1 (IL-1) signaling pathway. It selectively dephosphorylates IKKbeta, a key enzyme in the NF-kappaB activation cascade.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Interleukin-1 (IL-1) is a pro-inflammatory cytokine that triggers signaling cascades, including Nuclear Factor kappaB (NF-kappaB) activation, leading to inflammatory gene expression.
- The mechanisms by which protein phosphatases regulate IL-1-induced NF-kappaB activation are not fully understood.
Purpose of the Study:
- To investigate the role of mouse protein serine/threonine phosphatase 2Ceta-2 (PP2Ceta-2) in the IL-1-NF-kappaB signaling pathway.
- To elucidate the molecular mechanism of PP2Ceta-2's action in regulating inflammation.
Main Methods:
- Ectopic expression of PP2Ceta-2 in human embryonic kidney (HEK293IL-1RI) cells.
- Investigating the effect of PP2Ceta-2 on NF-kappaB activation mediated by TAK1 and IKKbeta.
- Utilizing small interfering RNA (siRNA) for PP2Ceta-2 knockdown in HeLa cells.
- In vitro dephosphorylation assays of IKKbeta by PP2Ceta-2.
Main Results:
- PP2Ceta-2 expression inhibited IL-1-induced NF-kappaB activation.
- PP2Ceta-2 suppressed NF-kappaB activation downstream of TAK1 and IKKbeta.
- PP2Ceta-2 knockdown enhanced IL-1-induced IKKbeta phosphorylation, IkappaBalpha destabilization, and IL-6 mRNA expression.
- PP2Ceta-2 directly dephosphorylated IKKbeta in vitro.
Conclusions:
- Mouse PP2Ceta-2 acts as a negative regulator of the IL-1-NF-kappaB signaling pathway.
- PP2Ceta-2 inhibits inflammation by selectively dephosphorylating IKKbeta, thereby preventing NF-kappaB activation.
Abstract:
IL-1 (interleukin-1) is a pro-inflammatory cytokine that has a variety of effects during the process of inflammation. Stimulating cells with IL-1 initiates a signalling cascade that includes the activation of NF-kappaB (nuclear factor kappaB), and subsequently induces a variety of inflammatory genes. Although the molecular mechanism for the IL-1-induced activation of NF-kappaB has been well documented, much less is known about the mechanism by which protein phosphatases down-regulate this pathway. Here we show that mouse PP2Ceta-2 (protein serine/threonine phosphatase 2Ceta-2), a novel member of the protein serine/threonine phosphatase 2C family, inhibits the IL-1-NF-kappaB signalling pathway. Ectopic expression of PP2Ceta-2 in human embryonic kidney HEK293IL-1RI cells inhibited the IL-1-induced activation of NF-kappaB. TAK1 (transforming-growth-factor-beta-activated kinase 1) mediates the IL-1 signalling pathway to NF-kappaB, and we observed that the TAK1-induced activation of NF-kappaB was suppressed by PP2Ceta-2 expression. Expression of IKKbeta [IkappaB (inhibitory kappaB) kinase beta], which lies downstream of TAK1, activates NF-kappaB, and this activation was also readily reversed by PP2Ceta-2 co-expression. Additionally, PP2Ceta-2 knockdown with small interfering RNA further stimulated the IL-1-enhanced phosphorylation of IKKbeta and destabilization of IkappaBalpha in HeLa cells. PP2Ceta-2 knockdown also increased the IL-1-induced expression of IL-6 mRNA. Furthermore, IKKbeta was readily dephosphorylated by PP2Ceta-2 in vitro. These results suggest that PP2Ceta-2 inhibits the IL-1-NF-kappaB signalling pathway by selectively dephosphorylating IKKbeta.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Regulation of Nuclear Protein Sorting
Amplifying Signals via Enzymatic Cascade
Co-activators and Co-repressors

